Author

Kozi Ichiyama

Observed name: KOZI ICHIYAMA

Institutions: St. Luke's-Roosevelt Hospital Center, Columbia University Irving Medical Center

Observed institutions: Tokyo Medical and Dental University, St. Luke's-Roosevelt Hospital Center, University of Massachusetts Chan Medical School, Columbia University Irving Medical Center, University Teaching Hospital, University of the Ryukyus, Chiba Institute of Technology

OpenAlex ID: A5019788354

A duodenally absorbable CXC chemokine receptor 4 antagonist, KRH-1636, exhibits a potent and selective anti-HIV-1 activity

2003 · Kozi Ichiyama, Sei Yokoyama-Kumakura, et al. · Proceedings of the National Academy of Sciences · 156

Analysis of HIV-1 Viral Infectivity Factor-mediated Proteasome-dependent Depletion of APOBEC3G

2004 · Michael J. Wichroski, Kozi Ichiyama, et al. · Journal of Biological Chemistry · 73

Testing antiretroviral drug efficacy in conventional mice infected with chimeric HIV-1

2007 · Eran Hadas, Alejandra Borjabad, et al. · AIDS · 48

Design and synthesis of a novel peptidomimetic inhibitor of HIV-1 Tat–TAR interactions: Squaryldiamide as a new potential bioisostere of unsubstituted guanidine

2005 · Chi-Wan Lee, Hong Cao, et al. · Bioorganic & Medicinal Chemistry Letters · 38

Emergence of New HIV-1 Subtypes Other Than Subtype C among Antenatal Women in Lusaka, Zambia

2001 · Ray Handema, Hiroshi Terunuma, et al. · AIDS Research and Human Retroviruses · 14

Design and Synthesis of a Novel Peptidomimetic Inhibitor of HIV‐1 Tat—TAR Interactions: Squaryldiamide as a New Potential Bioisostere of Unsubstituted Guanidine.

2005 · Chi‐Wan Lee, Hong Cao, et al. · ChemInform

[Replication inhibitors targeting early events in the HIV-1 life cycle].

2002 · Kozi Ichiyama, Naoki Yamamoto · PubMed

Drug susceptibilities and clinical manifestations of Mycobacterium Tuberculosis in Zambia.

2002 · SATOSHI MITARAI, CHARITY HABEENZU, et al. · Japanese Journal of Tropical Medicine and Hygiene

Works count: 8

Citation count: 329

H-index: 5

I10-index: 5